Can-Fite BioPharma Licenses Potential Inflammatory Disease Rxs from Leiden U, NIH

Can-Fite will pay Leiden University and NIH an upfront fee and annual minimal royalties; milestone payments until marketing approval; and royalty payments on net sales of future products.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.